(Q45039320)

8 December 2017

title

Attenuation of transplant arteriosclerosis by oral feeding of major histocompatibility complex encoding chitosan-DNA nanoparticles (English)

1 reference

8 December 2017

Katja Goldmann

1

1 reference

8 December 2017

Julia Hoffmann

2

1 reference

8 December 2017

Sebastian Eckl

3

1 reference

8 December 2017

Bernd M Spriewald

4

1 reference

8 December 2017

Stephan M Ensminger

5

1 reference

8 December 2017

publication date

5 December 2012

1 reference

8 December 2017

published in

Transplant Immunology

1 reference

8 December 2017

volume

28

1 reference

8 December 2017

issue

1

1 reference

8 December 2017

page(s)

9-13

1 reference

Alloantigen-induced specific immunological unresponsiveness

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.11.007

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.11.007

Intervention in autoimmune diabetes by targeting the gut immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.11.007

Oral tolerance induced by continuous feeding: enhanced up-regulation of transforming growth factor-beta/interleukin-10 and suppression of experimental autoimmune encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.11.007

Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.11.007

Immunosuppression of rat myasthenia gravis by oral administration of a syngeneic acetylcholine receptor fragment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.11.007

Nondepleting anti-CD4 monoclonal antibody enhances the ability of oral alloantigen delivery to induce indefinite survival of cardiac allografts: oral tolerance to alloantigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.11.007

Coupling of oral human or porcine insulin to the B subunit of cholera toxin (CTB) overcomes critical antigenic differences for prevention of type I diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.11.007

A novel recombinant peptide containing only two T-cell tolerance epitopes of chicken type II collagen that suppresses collagen-induced arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.11.007

Oral feeding of an immunodominant MHC donor-derived synthetic class I peptide prolongs graft survival of heterotopic cardiac allografts in a high-responder rat strain combination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.11.007

Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.11.007

Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabète Insuline Orale group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.11.007

Control of rheumatoid arthritis by oral tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.11.007

Effects of oral administration of type II collagen on rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.11.007

Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.11.007

Recent advances on chitosan-based micro- and nanoparticles in drug delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.11.007

Chitosan nanoparticles for plasmid DNA delivery: effect of chitosan molecular structure on formulation and release characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.11.007

Advances in using chitosan-based nanoparticles for in vitro and in vivo drug and gene delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.11.007

Oral gene delivery with chitosan--DNA nanoparticles generates immunologic protection in a murine model of peanut allergy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.11.007

Vaccination with plasmid DNA activates dendritic cells via Toll-like receptor 9 (TLR9) but functions in TLR9-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.11.007

Development of a mouse aortic transplant model of chronic rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.11.007

A pilot study on the immunological effects of oral administration of donor major histocompatibility complex class II peptides in renal transplant recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.11.007

Syngeneic bone marrow transduced with a recombinant retroviral vector to express endoplasmic reticulum signal-sequence-deleted major histocompatibility complex class-I alloantigen can induce specific immunologic unresponsiveness in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.11.007

Oral gene application using chitosan-DNA nanoparticles induces transferable tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.11.007

Linked unresponsiveness: early cytokine gene expression profiles in cardiac allografts following pretreatment of recipients with bone marrow cells expressing donor MHC alloantigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.11.007

Pretransplant administration of a single donor class I major histocompatibility complex molecule is sufficient for the indefinite survival of fully allogeneic cardiac allografts: evidence for linked epitope suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.11.007

CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.11.007

Regulation of transplant arteriosclerosis by CD25+CD4+ T cells generated to alloantigen in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.11.007

In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.11.007

Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.11.007

Induction of anergy or active suppression following oral tolerance is determined by antigen dosage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.11.007

Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.11.007

10.1016/J.TRIM.2012.11.007

7 January 2021

Identifiers

DOI

1 reference

8 December 2017

1 reference